$HUN

Huntsman anticipates early-2027 close of Olin merger while targeting $300M synergies plus $100M from expiring chlorine contracts (NYSE:HUN)

Huntsman Corporation (HUN) expects to complete its merger with Olin by early 2027, targeting $300M in synergies and an additional $100M from expiring chlorine contracts. The company anticipates a $100M improvement in 2026 EBITDA compared to 2025, according to CEO Peter Huntsman.

Original reporting
Published Nov 3, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$HUN
Bullish
high confidence
Mentioned
$HUN · $OLN
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$HUNBullishMed
01

Why it matters

The disclosed EBITDA improvement reinforces confidence in the merger's value creation.

02

Market read

Guidance lift is a fresh, material data point for HUN, offering a short‑term trading edge.

03

What to watch

Potential integration risks from the pending Olin merger could offset short‑term gains.

Relevance 7/10Novelty 6/10Timing: post‑earnings call today

Background

Huntsman Corp. is progressing toward its planned merger with Olin Corp., targeting $300M synergies.

Company-level read

Ticker impact

$HUNBullishHigh confidence
Context

Management announced >$100M EBITDA improvement for 2026 versus 2025 during the Q3 earnings call.

Expected impact

upward pressure as investors price in higher earnings outlook

Evidence & confidence

EBITDA improvement of over $100M is material for a mid‑cap chemical company and signals operational success.

Market effects

Improved earnings may boost sentiment in the specialty chemicals sector.

North American chemical stocks could see modest gains.

Limited to investors tracking mid‑cap industrial firms.

Counterpoint

If cost inflation accelerates, the EBITDA boost may be temporary.

Key entities

  • Huntsman Corporation

    Specialty chemicals producer (NYSE:HUN).

  • Peter Huntsman

    Chairman, President & CEO of Huntsman.

Related articles

$HUNMed

Huntsman Q3 Earnings Call Highlights

Huntsman (HUN) reported Q3 earnings, noting seasonal slowing and higher raw-material costs in North American MDI markets. The company expects 2027 industry MDI growth to be flat to 2% and sees growth opportunities in advanced materials and automotive applications. Huntsman generated $82M in free cash flow in Q3 and anticipates substantial cash inflow in Q4. Europe remains challenging due to high energy costs, while China's market shows stability.

$HUNMed

Huntsman Corp (HUN) (Q3 2026) Earnings Call Highlights: $100 Million EBITDA Boost

Huntsman Corp (HUN) reported a $100M EBITDA boost in Q3 2026, with CEO Peter Huntsman expressing confidence in meeting $300M synergy targets from the Olin merger. He discussed market positioning, cost management, and growth expectations, including GDP-plus growth in Advanced Materials through 2027. The company expects to cover its dividend and capex with operating cash flow, despite minimal cash flow in the first nine months.

$HUNMedAI 8/10

Huntsman: Q3 Earnings Snapshot

Huntsman Corp. (HUN) reported a Q3 loss of $18M, or 10 cents per share, missing analyst expectations of 7 cents per share. Adjusted earnings were 4 cents per share. Revenue was $1.72B, exceeding forecasts of $1.6B.